Home / Collections / Test Only Products / Floré Gastrointestinal Pathogen Test - Previous Sample

Floré Gastrointestinal Pathogen Test - Previous Sample

$129.00 $159.00 saving $30.00
Floré Gastrointestinal Pathogen Test - Previous Sample

The Floré Gastrointestinal Pathogen Test is a multiplexed nucleic acid test intended for the qualitative detection and identification of various pathogenic microbes that may cause gastroenteritis and infectious colitis. When used in conjunction with clinical evaluation, laboratory findings, and epidemiological information Floré Gastrointestinal Pathogen test results can be used for the diagnosis of gastrointestinal infections in individuals exhibiting signs and symptoms of gastroenteritis or infectious colitis.


  • Detect and identify more than 90% of the causative bacterial, viral, and parasitic agents of gastroenteritis.
  • Get fast, comprehensive results in just 5 days.
  • Simplify your results: 1 sample to detect 14 pathogens
  • Higher sensitivity and specificity as compared to other traditional assay

Giving Back

We are delighted to provide a portion of our proceeds to the Crohn's & Colitis Foundation, a non-profit organization dedicated to finding cures for Crohn's & Colitis and improving the quality of those living with these diseases. To learn more about the Crohn's & Colitis Foundation, please visit their website:

 Crohn's & Colitis Foundation

The Process

Our clinical lab will send out the needed collection materials for processing of your sample. Once you return the sample, we will take it from there.


Collect and Send

It takes only five minutes.



Our test is a PCR based test utilizing the xMAP bead hybridization and detection technology that simultaneously detects multiple bacterial, viral and parasitic pathogens in a single test.


Review Results

Results will be uploaded to our portal and available for review by you and your provider.

You should take this test if you’re suffering from:

  • Chronic and constant abdominal pain
  • Constipation/Diarrhea
  • Mucus in stool
  • Gassiness or Bloating
  • Travelers’ diarrhea

What does this Test Detect:

  • Infectious gastroenteritis
  • Infectious colitis
  • Acute gastritis
  • Community outbreaks
  • Foodborne GI illnesses
  • Epidemics/Pandemics

How it Works

GPP (GI pathogen panel)is a qualitative multiplex test that can simultaneously detect and identify multiple bacterial, viral, and parasitic GI pathogens from individuals with signs and symptoms of infectious colitis or gastroenteritis.The panel detects the GI pathogen types, subtypes and toxin genes described in the table.The GPP assay includes a reverse transcription polymerase chain reaction (RT-PCR) with xTAG universal tag sorting system and a subsequent bead hybridization utilizing the xMAP Technology platform. This is an efficient technology that enables the analyzer to capture and detect specific analytes of all target pathogens in the panel, from the single sample provided.

Bacteria & Bacterial Toxins
  • Campylobacter (C. jejuni, C. coli and C. lari only)
  • Clostridium difficile (C. difficile) toxin A/B
  • Escherichia coli (E. coli) O157
  • Enterotoxigenic E. coli (ETEC) LT/ST
  • Shiga-like Toxin producing E. coli (STEC) stx1/stx2
  • Salmonella (Salmonella enterica)
  • Shigella (S. boydii, S. sonnei, S. flexneri, and S. dysenteriae)
  • Vibrio cholerae, cholera toxin gene (ctx)
  • Cryptosporidium (C. parvum and C. hominis)
  • Entamoeba histolytica (E. histolytica)
  • Giardia (G. lamblia only - also known as G. intestinalis and G. duodenalis)
  • Adenovirus 40/41
  • Norovirus GI/GII
  • Rotavirus A


  1. Slutsker L, Ries AA, Greene KD, et al. Escherichia coli O157:H7 diarrhea in the United States: clinical and epidemiologic features. Ann Intern Med 1997;126(7):505–13.
  2. Fotedar R, Stark D, Beebe N, et al. PCR detection of entamoeba histolytica, entamoeba dispar, and entamoeba moshkovskii in stool samples from Sydney, Australia. J Clin Microbiol 2007;45(3):1035–7.
  3. Tuncay S, et al. The evaluation of the techniques used for diagnosis of entamoeba histolytica in stool specimens. TürkiyeParazitolDerg 2007;31(3):188–93.
  4. Luminex Corporation | xTAG GPP Package Insert (2013).
  5. Nexus. GPP Impact: Time and Motion Study at Royal Liverpool Hospital. Internal Data. November, 2012
  6. Svraka S, et al. Novel approach for detection of enteric viruses to enable syndrome surveillance of acute viral gastroenteritis. J Clin Microbiol 2009;47(6)1674-9.
  7. Hansen G, et al. Clostridium difficile: Navigating the testing options for diagnosis. Clin Lab News 2010;36(7).
  8. M’ikanatha NM, Dettinger LA, Perry A, et al. Culturing stool specimens for Campylobacter spp., Pennsylvania, USA. Emerg Infect Dis 2012;18(3).
  9. Aldeen WE, Carroll K, Robison A, et al. Comparison of nine commercially available enzyme-linked immunosorbent assays for detection of t in fecal specimens J Clin Microbiol 1998 36(5):1338.
  10. Staat MA, et al. Intestinal parasite screening in internationally adopted children: Importance of multiple stool specimens. Pediatrics 2011;128(3):613-22.


The Floré GPP test is done in a CLIA certified laboratory, Floré Laboratories. GPP incorporates multiplex reverse-transcriptase PCR (RT-PCR) with the xTAG universal tag sorting system on the Luminex xMAP platform. Positive results are presumptive and must be confirmed by FDA cleared tests or other acceptable reference methods and do not rule out co-infection with other organisms that are not detected in this test panel. The results of this test should not be used as the sole basis for diagnosis, treatment, or other patient management decisions. Negative results in the setting of clinical illness compatible with gastroenteritis may be due to infection by pathogens that are not detected by this test or non-infectious causes such as ulcerative colitis, irritable bowel syndrome, or Crohn’s disease. This GI panel test is not intended to monitor or guide treatment for C. difficile infections. This test was validated and verified by Floré Laboratories to match the manufacturer's validation data. CLIA ID: 05D2194956